Fig. 4

Comparison of breast cancer susceptibility genes (CSG) in male versus female breast cancer and genome-wide loss of heterozygosity (gLOH) in male breast cancer. a Fraction of breast cancer susceptibility genes (CSG) in male (n = 57) and female (n = 418) breast cancer patients. b Median genome-wide loss of heterozygosity (gLOH) across male breast cancer (MaBC) patients, stratified by breast CSG gene prevalence. Asterisk reflects adjusted p < 0.05